CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

Background Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations. c-CBL is an E3 ubiquitin ligase and adaptor molecule important in normal homeostasis and cancer. We determined the genetic variations of c-CBL, relationship to receptor tyrosine kinases (EGFR and MET), and functionality in NSCLC. Methods and Findings Using archival formalin-fixed paraffin embedded (FFPE) extracted genomic DNA, we show that c-CBL mutations occur in somatic fashion for lung cancers. c-CBL mutations were not mutually exclusive of MET or EGFR mutations; however they were independent of p53 and KRAS mutations. In normal/tumor pairwise analysis, there was significant loss of heterozygosity (LOH) for the c-CBL locus (22%, n = 8/37) and none of these samples revealed any mutation in the remaining copy of c-CBL. The c-CBL LOH also positively correlated with EGFR and MET mutations observed in the same samples. Using select c-CBL somatic mutations such as S80N/H94Y, Q249E and W802* (obtained from Caucasian, Taiwanese and African-American samples, respectively) transfected in NSCLC cell lines, there was increased cell viability and cell motility. Conclusions Taking the overall mutation rate of c-CBL to be a combination as somatic missense mutation and LOH, it is clear that c-CBL is highly mutated in lung cancers and may play an essential role in lung tumorigenesis and metastasis.

• Publication year

  2010

• Venue

  PLoS ONE

• Publication date

  2010-01-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0008972PMID 20126411PMCID 2813301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2009

  2010cited by this paper
• Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

  2009cited by this paper
• CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

  2009cited by this paper
• Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers

  2009cited by this paper
• Novel Mutations in c-Cbl Ubiquitin Ligase Gene in Taiwanese Lung Cancer

  2009cited by this paper
• Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Somatic mutations affect key pathways in lung adenocarcinoma

  2008cited by this paper
• Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

  2008cited by this paper
• Drosophila cbl Is Essential for Control of Cell Death and Cell Differentiation during Eye Development

  2008cited by this paper
• 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.

  2008cited by this paper
• Ubiquitin and ubiquitin-like proteins in protein regulation.

  2007cited by this paper
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

  2007cited by this paper
• Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.

  2007cited by this paper
• Flt3-dependent transformation by inactivating c-Cbl mutations in AML.

  2007influential reference
• Review of clinic trials: agents targeting c-Met.

  2007cited by this paper
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

  2007cited by this paper
• Structural Basis for UBA-mediated Dimerization of c-Cbl Ubiquitin Ligase*

  2007cited by this paper
• Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling

  2007cited by this paper
• Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.

  2006cited by this paper
• The Cbl family proteins: Ring leaders in regulation of cell signaling

  2006influential reference
• Comparative genomic organization of the cbl genes.

  2003cited by this paper
• Lung cancer in African Americans.

  2003cited by this paper
• The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system

  2002cited by this paper
• The interface of receptor trafficking and signalling.

  2001cited by this paper
• Cbl: many adaptations to regulate protein tyrosine kinases

  2001cited by this paper
• Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

  2001cited by this paper
• Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein.

  2001cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• Threonine Phosphorylation Diverts Internalized Epidermal Growth Factor Receptors from a Degradative Pathway to the Recycling Endosome*

  2000cited by this paper
• The Evolutionarily Conserved N-terminal Region of Cbl Is Sufficient to Enhance Down-regulation of the Epidermal Growth Factor Receptor*

  2000cited by this paper
• cbl-b inhibits epidermal growth factor receptor signaling

  1999cited by this paper
• Cbl-mediated Negative Regulation of Platelet-derived Growth Factor Receptor-dependent Cell Proliferation

  1999cited by this paper
• Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase

  1999cited by this paper
• The RING Finger of c-Cbl Mediates Desensitization of the Epidermal Growth Factor Receptor*

  1999influential reference
• Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice

  1998cited by this paper
• Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

  1998cited by this paper
• EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene

  1997cited by this paper
• Tyrosine Phosphorylation of Cbl upon Epidermal Growth Factor (EGF) Stimulation and Its Association with EGF Receptor and Downstream Signaling Proteins*

  1996cited by this paper
• Coupling of the Proto-oncogene Product c-Cbl to the Epidermal Growth Factor Receptor (*)

  1995cited by this paper
• Cancer statistics

  1989cited by this paper
• The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein

  1989cited by this paper

• An Observatory for the MET Oncogene: A Guide for Targeted Therapies

  2023cites this paper
• MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy

  2023cites this paper
• Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential

  2022cites this paper
• The RING finger protein family in health and disease

  2022cites this paper
• Role of CBL Mutations in Cancer and Non-Malignant Phenotype

  2022cites this paper
• MET∆14 promotes a ligand-dependent, AKT-driven invasive growth

  2022cites this paper
• The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer

  2021cites this paper
• Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes

  2021cites this paper
• MET receptor in oncology: From biomarker to therapeutic target.

  2020cites this paper
• Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations

  2020cites this paper
• Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis

  2020influential citation
• Epigenome-Wide Tobacco-Related Methylation Signature Identification and Their Multilevel Regulatory Network Inference for Lung Adenocarcinoma

  2020cites this paper
• Trametes robiniophila Murr in the treatment of breast cancer.

  2020cites this paper
• miRNA-122-5p stimulates the proliferation and DNA synthesis and inhibits the early apoptosis of human spermatogonial stem cells by targeting CBL and competing with lncRNA CASC7

  2020cites this paper
• Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer

  2019cites this paper
• Loss of function Cbl-c mutations in solid tumors

  2019cites this paper
• Targeted Therapies for Lung Cancer

  2019cites this paper
• Predicting E3 Ubiquitin Ligases as Possible Promising Biomarkers for Brain Tumors

  2019cites this paper
• Photocrosslinking Activity-Based Probes for Ubiquitin RING E3 Ligases

  2019cites this paper
• EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma

  2019cites this paper
• MET as a Therapeutic Target: Have Clinical Outcomes Been “MET” in Lung Cancer?

  2019cites this paper
• Dissecting the role of His domain protein tyrosine phosphatase/PTPN23 and ESCRTs in sorting activated epidermal growth factor receptor to the multivesicular body

  2018cites this paper
• Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia

  2018cites this paper
• Prostate cancer health disparities: An immuno-biological perspective.

  2018cites this paper
• C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.

  2018cites this paper
• Regulation of EGFR Endocytosis by CBL During Mitosis

  2018cites this paper
• HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53

  2018cites this paper
• c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.

  2018cites this paper
• The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src

  2018cites this paper
• A prize-collecting Steiner tree application for signature selection to stratify diffuse large B-cell lymphoma subtypes

  2018cites this paper
• Genome-wide identification of CDC34 that stabilizes EGFR and promotes lung carcinogenesis

  2018cites this paper
• Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer

  2018cites this paper
• Ubiquitination and the Regulation of Membrane Proteins.

  2017cites this paper
• Functional variants in DCAF4 associated with lung cancer risk in European populations

  2017cites this paper
• PCSF: An R-package for network-based interpretation of high-throughput data

  2017cites this paper
• Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

  2017cites this paper
• Degrons in cancer

  2017cites this paper
• MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale

  2017cites this paper
• Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL

  2017cites this paper
• c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors

  2016influential citation
• Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non-Small-Cell Lung Cancer.

  2016cites this paper
• High c-Cbl expression in gliomas is associated with tumor progression and poor prognosis

  2016cites this paper
• The lysosome as a command-and-control center for cellular metabolism

  2016cites this paper
• c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus

  2016cites this paper
• Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma

  2016influential citation
• Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.

  2016cites this paper
• The myelodysplastic syndromes

  2016cites this paper
• Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation

  2016cites this paper
• MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer.

  2016cites this paper
• Identification of new genetic alterations and potential biomarkers in papillary thyroid carcinoma

  2016cites this paper
• C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype

  2015cites this paper
• New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma

  2015cites this paper
• Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations.

  2015cites this paper
• Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.

  2015cites this paper
• Redox biology in normal cells and cancer: restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment.

  2015cites this paper
• Deleterious c-Cbl Exon Skipping Contributes to Human Glioma12

  2015cites this paper
• Cell Regulation by Phosphotyrosine-Targeted Ubiquitin Ligases

  2015cites this paper
• Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

  2015cites this paper
• Dysregulation of ubiquitin ligases in cancer.

  2015cites this paper
• H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b

  2015cites this paper
• The role and therapeutic implications of RING‐finger E3 ubiquitin ligases in hepatocellular carcinoma

  2015cites this paper
• Figure 2 : Fluorescence In Situ Hybridization Image of ROS 1 Translocated Lung Adenocarcinoma

  2014cites this paper
• Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

  2014cites this paper
• The role of the ubiquitin-proteasome pathway in cancer development and treatment.

  2014cites this paper
• c-Cbl regulates αPix-mediated cell migration and invasion.

  2014cites this paper
• Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.

  2014cites this paper
• Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition

  2014cites this paper
• Germline CBL mutation associated with a noonan‐like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23

  2014cites this paper
• Cool‐1‐Mediated Inhibition of c‐Cbl Modulates Multiple Critical Properties of Glioblastomas, Including the Ability to Generate Tumors In Vivo

  2014cites this paper
• Small Cell Lung Cancer - Inhibitor LY2801653 in Non Dramatic Antitumor Effects of the Dual MET/RON Small-Molecule

  2014cites this paper
• The Proto-Oncoprotein c-Cbl Protects Cells against Oxidative Stress by Down-Regulating Apoptosis and is Highly Expressed in Several Cancers

  2014cites this paper
• Molecular Pathways: Cbl Proteins in Tumorigenesis and Antitumor Immunity—Opportunities for Cancer Treatment

  2014cites this paper
• An Intronic microRNA Links Rb/E2F and EGFR Signaling

  2014cites this paper
• The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.

  2014cites this paper
• Cbl-b Enhances Sensitivity to 5-Fluorouracil via EGFR- and Mitochondria-Mediated Pathways in Gastric Cancer Cells

  2013cites this paper
• Lack of RING finger domain (RFD) mutations of the c-cbl gene in oral squamous cell carcinomas in Chennai, India.

  2013cites this paper
• E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis

  2013cites this paper
• MET as a possible target for non-small-cell lung cancer.

  2013cites this paper
• Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.

  2013cites this paper
• Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.

  2013cites this paper
• Role of E3 ubiquitin ligases in lung cancer.

  2013cites this paper
• Endocytosis and the Regulation of Cell Signaling, Cell Adhesion, and Epithelial to Mesenchymal Transition in Cancer

  2013cites this paper
• Mechanism of ubiquitin transfer by RING E3 ligases

  2013cites this paper
• Cbl as a Master Regulator of Receptor Tyrosine Kinase Trafficking

  2013cites this paper
• RE SE EE DUB Proteasome Lysosome MVB / Late Endosome ESCRT Degradative Pathway EGF CblUbiquitin EGFR Associated Protiens Recycling Pathway

  2012cites this paper
• Rôle de l'ubiquitine c-Cbl dans l'ostéogenèse normale

  2012cites this paper
• CBL mutations in myeloproliferative neoplasms are also found in the gene’s proline-rich domain and in patients with the V617FJAK2

  2012cites this paper
• Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.

  2012cites this paper
• Met Kinase-dependent Loss of the E3 Ligase Cbl in Gastric Cancer*

  2012cites this paper
• CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling

  2012cites this paper
• [Implication of the ubiquitin ligase c-Cbl in bone formation and tumorigenesis].

  2012cites this paper
• A Novel Classification of Lung Cancer into Molecular Subtypes

  2012influential citation
• Rôle de l’ubiquitine ligase c-Cbl dans l’ostéogenèse normale et cancéreuse

  2012cites this paper
• CBL mutations in myeloproliferative neoplasms are also found in its proline-rich domain and in patients with the V 617 FJAK 2 by

  2012cites this paper
• Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.

  2012cites this paper
• The role of the c-Met pathway in lung cancer and the potential for targeted therapy

  2011cites this paper
• Investigating a co-operative link between TGF-β and Lyn kinase in Chronic Myeloid Leukaemia

  2011cites this paper
• Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerations.

  2011cites this paper
• Personalized treatment of lung cancer.

  2011cites this paper
• c-Cbl、Cbl-b和EGFR在非小细胞肺癌中的表达及其预后价值

  2011cites this paper